Introduction
Seizure is a common neurological disorder in children [1, 2] .
Antiepileptic drugs (AEDs) are usually used for long-term. The medication is only tapered after a seizure-free interval to minimize the risk of recurrence [3, 4] . There are many studies on the risk of seizure recurrence after withdrawal of AEDs, which varies from 10% to 50%, partly depending on the study designs [3] [4] [5] [6] [7] .
The risk factors of seizure recurrence identified include older age of onset of epilepsy, remote symptomatic epilepsy, abnormal electroencephalography (EEG), some epilepsy syndromes such as juvenile myoclonic epilepsy, severity of epilepsies, and those with family history [8] [9] [10] [11] [12] [13] [14] [15] . There are to date only rare reports on risk of seizure recurrence after AED withdrawal in Egypt. The objectives of this study were to determine the incidence and risk factors of seizure recurrence in multihandicapped Egyptian children with epilepsy after withdrawal of antiepileptic drugs (AEDs).
Methods
This was a prospective study from January 1995 to January 2016.
The study population was Egyptian multihandicapped children with epilepsy followed up in the outpatient clinic of Centre for Children with Special Needs; Egyptian Integrated Care Association (CCSN; EICA), Cairo, Egypt. The eligible children were less than withdrawal, the patients were then followed up to look for seizure recurrence.
Statistical Analysis
A survival analysis was performed with seizure recurrence as the hazard ratio and the interval of seizure recurrence (failure time) start after complete drug withdrawal. Log rank test was used for univariate analysis and Cox proportional-hazard model was used for multivariate analysis for risk factors of seizure recurrence.
All statistical tests were 2-tailed. The p-value of less than 0.05 was regarded as statistically significant.
Results
A total of 162 patients (85 Males and 77 Females), selected from population of 7568 patients, were enrolled in this study, which was from January 1995 to January 2016. The characteristics of patients are shown in Table 1 . As shown, the average age at onset of epilepsy was 14 months patients and behavioral disturbances in 38 patients (Table 2) . For example, the proportion with neurological deficit in the MRC trial was 22-24%.9 Remote symptomatic epilepsy, presence of neurological deficits particularly mental retardation, have been
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shown to be associated with poorer prognosis [8] [9] [10] [11] [12] [13] [14] [15] [16] . The average seizure free duration before commencing AED withdrawal in our patients is 48.3 months, which is relatively long. Longer period of seizure freedom before AED withdrawal is associated with lower seizure recurrence [7, 17] . In this study, we found that patients with polypharmacy had the risk of seizure recurrence four times more than monotherapy. Not surprisingly, patients who needed polypharmacy reflect their disease being more severe than those requiring monotherapy. We found that patients with neurological deficits had the risk of seizure recurrence more than five times more than who suffer no neurological deficits. Not surprisingly, patients who suffer neurological deficits reflect their disease being anatomical and more severe than those without anatomical lesions. We could not find types of seizure, age at onset of epilepsy, sex, and seizure-free interval during medication as risk factors of recurrence which are different from previous studies [8] [9] [10] [11] [12] 18] .
EEG abnormalities which have been shown to be a risk factor of recurrence10 were excluded from our group as we put an inclusion criteria that the eligible children were less than 13 years, seizurefree for at least 24 months, with two normal EEG records, separated by 6 months.
Conclusion
Risk of seizure recurrence after AED withdrawal in multiply handicapped Egyptian children, in this study, was high at 47.5%.
